Lilly Eli & Co

Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos.

The jury in Lafayette, La., awarded the plaintiff $6 billion in punitive damages from Takeda, the U.S. arm of Japan's largest pharmaceutical firm, and $3 billion from Eli Lilly. The jury also gave the plaintiff compensatory damages of nearly $1.5 million.

Legal experts said the high penalty, which they expect will be reduced on appeal, sends a signal to the pharmaceutical industry to provide customers with proper warnings about the dangers of...